Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma Statistics

Total Valuation

PPCB has a market cap or net worth of $18.95 million. The enterprise value is $19.64 million.

Market Cap	18.95M
Enterprise Value	19.64M

Important Dates

The last earnings date was Tuesday, September 30, 2025.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

PPCB has 12.81 million shares outstanding.

Current Share Class	12.81M
Shares Outstanding	12.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+168.42%
Owned by Insiders (%)	65.26%
Owned by Institutions (%)	3.90%
Float	3.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.16
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.12.

Current Ratio	1.50
Quick Ratio	0.00
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-101.60

Financial Efficiency

Return on equity (ROE) is -1,163.67% and return on invested capital (ROIC) is -559.26%.

Return on Equity (ROE)	-1,163.67%
Return on Assets (ROA)	-363.36%
Return on Invested Capital (ROIC)	-559.26%
Return on Capital Employed (ROCE)	-407.57%
Revenue Per Employee	n/a
Profits Per Employee	-$29.46M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.01% in the last 52 weeks. The beta is 19,964.30, so PPCB's price volatility has been higher than the market average.

Beta (5Y)	19,964.30
52-Week Price Change	-94.01%
50-Day Moving Average	2.45
200-Day Moving Average	8.29
Relative Strength Index (RSI)	37.14
Average Volume (20 Days)	342,373

Short Selling Information

The latest short interest is 212,160, so 1.66% of the outstanding shares have been sold short.

Short Interest	212,160
Short Previous Month	171,527
Short % of Shares Out	1.66%
Short % of Float	6.65%
Short Ratio (days to cover)	0.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.28M
Pretax Income	-58.92M
Net Income	-58.92M
EBITDA	-57.28M
EBIT	-57.28M
Earnings Per Share (EPS)	-$14.85

Balance Sheet

The company has $12,088 in cash and $1.73 million in debt, giving a net cash position of -$1.71 million or -$0.13 per share.

Cash & Cash Equivalents	12,088
Total Debt	1.73M
Net Cash	-1.71M
Net Cash Per Share	-$0.13
Equity (Book Value)	13.91M
Book Value Per Share	1.20
Working Capital	2.77M

Cash Flow

Operating Cash Flow	-405,168
Capital Expenditures	n/a
Free Cash Flow	-405,168
FCF Per Share	-$0.03

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PPCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-328.64%
FCF Yield	-2.26%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:59,880.24.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	1:59,880.24

Scores

Altman Z-Score	n/a
Piotroski F-Score	2